| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Animal: DNA Viruses |
CRC Institute for Cancer Studies, The University of Birmingham, Edgbaston, Birmingham B15 2TA, UK1
Author for correspondence: Andrew I. Bell. Fax +44 121 4486. e-mail a.i.bell{at}bham.ac.uk
Co-operation between the Epstein–Barr virus (EBV)-coded leader protein EBNA-LP and the nuclear antigen EBNA2 appears to be critical for efficient virus-induced B cell transformation. Here we report the genetic analysis of EBNA-LP function using two transient co-transfection assays of co-operativity, activation of latent membrane protein 1 (LMP1) expression from a resident EBV genome in Akata-BL cells and activation of an EBNA2-responsive reporter construct. Small deletions were introduced into each of five conserved regions (CRs) of EBNA-LP sequence present in type 1 and type 2 EBV strains and in several primate lymphocryptovirus EBNA-LP homologues. Deletions within all three CRs in the EBNA-LP W1W2 repeat domain completely abrogated function, through inhibition of nuclear localization in the cases of CR1 and CR2 but not of CR3; deletions within CR4 and CR5 in the Y1Y2 unique domain had relatively little effect, yet loss of the whole Y2 sequence blocked activity. Alanine substitution of serine residues within potential phosphorylation sites identified two mutants of particular interest. Substitution of three such residues (S34,36,63) within W1W2 not only abrogated EBNA-LP activity but was associated with a complete loss of EBNA2 detectability in co-transfected cells, implying possible destabilization of the co-expressed EBNA2 protein. More importantly the individual substitution of S36 completely blocked EBNA-LP/EBNA2 co-operativity while retaining EBNA2 expression. We infer critical roles for the CR3 domain and for the S36 residue in EBNA-LP’s co-operative function.
This article has been cited by other articles:
|
|
 |
|
  W. Lucchesi, G. Brady, O. Dittrich-Breiholz, M. Kracht, R. Russ, and P. J. Farrell Differential Gene Regulation by Epstein-Barr Virus Type 1 and Type 2 EBNA2 J. Virol., August 1, 2008; 82(15): 7456 - 7466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Tierney, J. Nagra, I. Hutchings, C. Shannon-Lowe, M. Altmann, W. Hammerschmidt, A. Rickinson, and A. Bell Epstein-Barr Virus Exploits BSAP/Pax5 To Achieve the B-Cell Specificity of Its Growth-Transforming Program J. Virol., September 15, 2007; 81(18): 10092 - 10100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Garibal, E. Hollville, A. I. Bell, G. L. Kelly, B. Renouf, Y. Kawaguchi, A. B. Rickinson, and J. Wiels Truncated Form of the Epstein-Barr Virus Protein EBNA-LP Protects against Caspase-Dependent Apoptosis by Inhibiting Protein Phosphatase 2A J. Virol., July 15, 2007; 81(14): 7598 - 7607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-W. Peng, B. Zhao, H.-C. Chen, M.-L. Chou, C.-Y. Lai, S.-Z. Lin, H.-Y. Hsu, and E. Kieff Hsp72 up-regulates Epstein-Barr virus EBNALP coactivation with EBNA2 Blood, June 15, 2007; 109(12): 5447 - 5454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Portal, A. Rosendorff, and E. Kieff Epstein-Barr nuclear antigen leader protein coactivates transcription through interaction with histone deacetylase 4 PNAS, December 19, 2006; 103(51): 19278 - 19283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Fogg, A. Kaur, Y.-G. Cho, and F. Wang The CD8+ T-Cell Response to an Epstein-Barr Virus-Related Gammaherpesvirus Infecting Rhesus Macaques Provides Evidence for Immune Evasion by the EBNA-1 Homologue J. Virol., October 15, 2005; 79(20): 12681 - 12691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-H. Chiou, K.-C. Chow, C.-H. Yang, S.-F. Chiang, and C.-H. Lin Discovery of Epstein-Barr virus (EBV)-encoded RNA signal and EBV nuclear antigen leader protein DNA sequence in pet dogs J. Gen. Virol., April 1, 2005; 86(4): 899 - 905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Peng, S. C. Moses, J. Tan, E. Kremmer, and P. D. Ling The Epstein-Barr Virus EBNA-LP Protein Preferentially Coactivates EBNA2-Mediated Stimulation of Latent Membrane Proteins Expressed from the Viral Divergent Promoter J. Virol., April 1, 2005; 79(7): 4492 - 4505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-W. Peng, B. Zhao, and E. Kieff Four EBNA2 Domains Are Important for EBNALP Coactivation J. Virol., October 15, 2004; 78(20): 11439 - 11442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kanamori, S. Watanabe, R. Honma, M. Kuroda, S. Imai, K. Takada, N. Yamamoto, Y. Nishiyama, and Y. Kawaguchi Epstein-Barr Virus Nuclear Antigen Leader Protein Induces Expression of Thymus- and Activation-Regulated Chemokine in B Cells J. Virol., April 15, 2004; 78(8): 3984 - 3993. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kato, A. Yokoyama, Y. Tohya, H. Akashi, Y. Nishiyama, and Y. Kawaguchi Identification of protein kinases responsible for phosphorylation of Epstein-Barr virus nuclear antigen leader protein at serine-35, which regulates its coactivator function J. Gen. Virol., December 1, 2003; 84(12): 3381 - 3392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ning, A. M. Hahn, L. E. Huye, and J. S. Pagano Interferon Regulatory Factor 7 Regulates Expression of Epstein-Barr Virus Latent Membrane Protein 1: a Regulatory Circuit J. Virol., September 1, 2003; 77(17): 9359 - 9368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Igarashi, Y. Kawaguchi, K. Hirai, and F. Mizuno Physical interaction of Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) with human oestrogen-related receptor 1 (hERR1): hERR1 interacts with a conserved domain of EBNA-LP that is critical for EBV-induced B-cell immortalization J. Gen. Virol., January 1, 2003; 84(2): 319 - 327. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
